← Eichor
Study identifier: NCT06024993 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Dead Space in Mechanical Ventilation With Constant Expiratory Flow

Condition: Mechanical Ventilation · Artificial Respiration  ·  Sponsor: University Hospital, Antwerp

PhaseNA
Planned participants13
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

Conventional continuous mandatory mechanical ventilation relies on the passive recoil of the chest wall for expiration. This results in an exponentially decreasing expiratory flow. Flow controlled ventilation (FCV), a new ventilation mode with constant, continuous, controlled expiratory flow, has recently become clinically available and is increasingly being adopted for complex mechanical ventilation during surgery. In both clinical and pre-clinical settings, an improvement in ventilation (CO2 clearance) has been observed during FCV compared to conventional ventilation. Recently, Schranc et al. compared flow-controlled ventilation with pressure-regulated volume control in both double lung ventilation and one-lung ventilation in pigs. They report differences in dead space ventilation that may explain the improved CO2 clearance, although their study was not designed to compare dead space ventilation within the group of double lung ventilation. Dead space ventilation, or "wasted ventilation", is the ventilation of hypoperfused lung zones, and is clinically relevant, as it is a strong predictor of mortality in patients with the acute respiratory distress syndrome (ARDS) and is correlated with higher airway driving pressures which are thought to be injurious to the lung (lung stress). This trial aims to study the difference in dead space ventilation between conventional mechanical ventilation in volume-controlled mode and flow controlled-ventilation.

This description comes directly from the study's public registry record.

Talk to the study team

Carine Smitz  ·  +32 3 821 49 30  ·  carine.smitz@uza.be

Joke De Wachter  ·  +32 3 821 30 42  ·  joke.dewachter@uza.be

Always discuss trial participation with your own doctor first.

Locations (1)

Antwerp University Hospital (UZA)Edegem, Antwerp, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06024993